Home All News

All News

Internet And Biotech Related News

Mark Washo, Aphex Biocleanse

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...

PITTSFORD, N.Y., Nov. 12, 2020 PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...

Peter Schiff Predictions, One Year Ago – 2020.

Dow 18,500 on March 23rd Air Date. Eventually Maybe Soon, He Will Look Genius. ...they're gonna stay on...

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...

Mitesco (MITI) Announces Fourth Minneapolis and First Denver Lease for the Good Clinic.

Mitesco Announces Lease for Fourth Minneapolis Location and First Lease for the Good Clinic(TM) Operation in Denver MINNEAPOLIS, MN,...

Smart for Life (SMFL) Announces Letter of Intent to Acquire Largest Acquisition to Date.

6th Acquisition to Date is Expected to Add over $15 million of Revenue and to be Accretive to Earnings.

Stand Down VII: Could We Have a Down 20% Day?

Be Careful of Mondays. stand down: phrasal verb of stand 1. relax or cause to relax after a state of...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...
biotech stock review, dyadic

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho...

Latest article

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Principal Solar, Inc.Mon, March 20, 2023 at 7:30 AM EDT Institutional Analyst, Inc....

Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.

Going Short the Market. No Long Dissertation, No Rush. Market Risk Has Appeared, With Minimal Upside, So Time To Act.

We’re Bearish, but we’re up 257% in Provention Bio (PRVB) Today.

And up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of...